Evidence map›Paper›PMID 42027286›Full record

ArticleFrontiers in psychology2026

Tablet-based assessment protocol for cognition: development and preliminary usability testing of a cognitive screening tool.

Denise Mellace, Roberto Prandin, Carlo Manzoni, Angelica De Sandi, Sara Marceglia, Stefano Zago, Roberta Ferrucci

Abstract read
In one paragraph

Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Denise MellaceDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Roberto PrandinDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Carlo ManzoniDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Angelica De SandiFoundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Sara MarcegliaDepartment of Health Sciences, University of Milan, Milan, Italy.
Stefano ZagoFoundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Roberta FerrucciDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Computerized cognitive screening offers several advantages over traditional paper-and-pencil methods, including standardized administration, automated scoring, and scalable deployment. Touchscreen-based tools provide an intuitive and accessible interface for digital screening in both clinical and non-clinical contexts. However, there is continued interest in developing brief digital home-deliverable screening tools that encompass multiple cognitive domains and in systematically addressing usability during tool development. Methods: This paper presents the development and preliminary usability evaluation of TAP-COG, a tablet-based cognitive screening tool assessing processing speed, sustained attention, inhibitory control, short-term memory, and resistance to interference. TAP-COG comprises five self-administered tasks-Visual Reaction Time, Go/No-Go, Visual Recognition, Simon, and Interference-optimized for tablet interaction, requiring approximately 30 min to complete. Key performance metrics (reaction time, accuracy, errors) are automatically recorded. We conducted a usability study with 80 healthy adults (mean ± SD age: 40.75 ± 17.72; Montreal Cognitive Assessment: 28.45 ± 1.72) using the System Usability Scale. Results: All participants completed the battery independently and reported clear instructions and ease of use. Overall, 80% rated usability as "good" to "excellent," with no significant influence of age, education levels, or cognitive status on usability ratings. Conclusion: TAP-COG demonstrates high usability, supporting its potential as a scalable, self-administered cognitive screening tool. These findings justify further validation in larger and more diverse populations and highlight TAP-COG's promise for both research and clinical applications.

Indexed as

cognitive screeningearly detectionneuropsychological teststouch screen tabletusability

Identifiers

PMID42027286
PMCPMC13099291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.